Pliant Therapeutics (PLRX) Non-Current Assets (2019 - 2026)

Pliant Therapeutics (PLRX) has 8 years of Non-Current Assets data on file, last reported at $27.7 million in Q1 2026.

• Non-Current Assets for Q1 2026 came in at $27.7 million, down 17.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $119.8 million (down 14.45% YoY), and the FY2025 annual result was $28.8 million, down 17.02% from the prior year.
• Non-Current Assets fell to $27.7 million in Q1 2026 per PLRX's latest filing, from $28.8 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $36.2 million in Q2 2024 and troughed at $6.1 million in Q3 2023.
• A 5-year average of $21.6 million and a median of $27.7 million in 2026 frame the typical range for Non-Current Assets.
• The sharpest annual moves came in 2023 and 2024: Non-Current Assets tumbled 45.35% in 2023, then soared 481.4% in 2024.
• A 5-year view of Non-Current Assets shows it stood at $10.3 million in 2022, then plunged by 35.43% to $6.7 million in 2023, then soared by 421.42% to $34.7 million in 2024, then fell by 17.02% to $28.8 million in 2025, then fell by 3.87% to $27.7 million in 2026.
• Business Quant data shows PLRX's Non-Current Assets at $27.7 million in Q1 2026, $28.8 million in Q4 2025, and $31.0 million in Q3 2025.